| (210) | Number of the EPO application | 18770877 |
| (220) | Filing date of the EPO application | 2018.03.23 |
| (80) | EPO patent specification publication (B) | EPB nr. 31/2024, 2024.07.31 |
| (110) | EPO patent number | 3601239 |
| (21) | Number of the application | e 2020 0149 |
| (71) | Name(s) of applicant(s), code of the country | Jacobio Pharmaceuticals Co., Ltd., CN; |
| (72) | Name(s) of inventor(s), code of the country | MA Cunbo, CN;
GAO Panliang, CN;
HU Shaojing, CN;
XU Zilong, CN;
HAN Huifeng, CN;
WU Xinping, CN;
KANG Di, CN; |
| (73) | Name(s) of owner(s), code of the country | Jacobio Pharmaceuticals Co., Ltd., CN; |
| (54) | Title of the invention | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); C07D 491/107 (2006.01.01); C07D 495/10 (2006.01.01); C07D 471/20 (2006.01.01); A61K 31/497 (2006.01.01); A61P 35/00 (2006.01.01); C07D 405/14 (2006.01.01); C07D 491/113 (2006.01.01); C07D 491/20 (2006.01.01); C07D 513/10 (2006.01.01); C07F 9/6558 (2006.01.01); C07D 471/10 (2006.01.01) |
| (19) | Country | CN |
| (41) | Date of publication of the application | 2020.03.31 |
| (30) | Priority | PCT/IB2017/0516, 2017.03.23, WO |
| (86) | International application | PCT/IB2018/051973, 2018.03.23 |
| (87) | International publication | WO 2018/172984, 2018.09.27 |